Top Markets
#1 Pleasing Gold Pleasing Gold +1,498.80%
#2 Ontology Gas Ontology Gas +139.75%
#3 PulseChain PulseChain +57.88%
#4 Ontology Ontology +47.84%
#5 ConstitutionDAO ConstitutionDAO +32.32%
#6 BOOK OF MEME BOOK OF MEME +31.93%
#7 Collect on Fanable Collect on Fanable +28.19%
#8 Neiro Neiro +27.12%
#9 Pump.fun Pump.fun +23.47%
#10 Unit Pump Unit Pump +23.47%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
株式のランク #25851
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
株価
$15.31
最終同期: 2024-02-29
時価総額
$45.70M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Icosavax, Inc. (ICVX)

カテゴリー

Healthcare
Icosavax, Inc.（ICVX）の株価履歴
終値の最高値: $15.31 （2024-02-01）

終値の最安値: $29.91 （2021-07-01）
Icosavax, Inc. の株価履歴（2021 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2024 10.83%
2023 104.14%
2022 -70.48%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 36.71%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.86%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 385.07%
US